/WRBY
WRBY Stock - Warby Parker Inc.
Healthcare|Medical - Instruments & SuppliesNYSE
$26.39-1.27%
$0.34 (-1.27%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.89
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).86
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.37
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+18.2%upside
Target: $31.19
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WRBY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$26.13 – $26.65
TARGET (TP)$31.20
STOP LOSS$24.28
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.07
52W High$31.00
52W Low$13.63
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $771.32M | $669.76M | $598.11M | $540.80M | $393.72M |
| Gross Profit | $426.83M | $365.22M | $341.06M | $317.75M | $231.94M |
| Gross Margin | 55.3% | 54.5% | 57.0% | 58.8% | 58.9% |
| Operating Income | $-30,112,000 | $-71,996,000 | $-111,203,000 | $-143,661,000 | $-55,632,000 |
| Net Income | $-20,390,000 | $-63,197,000 | $-110,393,000 | $-144,271,000 | $-55,919,000 |
| Net Margin | -2.6% | -9.4% | -18.5% | -26.7% | -14.2% |
| EPS | $-0.17 | $-0.54 | $-0.96 | $-1.39 | $-0.50 |
Company Overview
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
13
65%
Hold / Neutral
6
30%
Sell / Underperform
1
5%
Analyst Consensus🟡 Mixed
13 Bullish7 Neutral/Bearish
Price Targets
$22
Average Target
↓ 18.3% Downside
Now
$13
Low
$22
Average
$30
High
Based on 21 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 10th 2025 | Citizens JMP | Upgrade | Mkt Outperform | $30 |
| November 7th 2025 | Telsey Advisory Group | Reiterated | Outperform | $24← $28 |
| August 1st 2025 | Telsey Advisory Group | Reiterated | Outperform | $28← $22 |
| July 10th 2025 | Citizens JMP | Downgrade | Market Perform | - |
| April 30th 2025 | Citigroup | Upgrade | Neutral | $17 |
| April 17th 2025 | Loop Capital | Upgrade | Buy | $27 |
| February 28th 2025 | Telsey Advisory Group | Reiterated | Outperform | $30← $28 |
| February 25th 2025 | ROTH MKM | Initiation | Neutral | $26 |
| February 5th 2025 | Citigroup | Downgrade | Sell | $23← $19 |
| January 17th 2025 | Evercore ISI | Downgrade | In-line | $23 |
| November 19th 2024 | Telsey Advisory Group | Reiterated | Outperform | $26← $22 |
| November 8th 2024 | Telsey Advisory Group | Reiterated | Outperform | $22← $19 |
| November 7th 2024 | William Blair | Upgrade | Outperform | - |
| October 21st 2024 | Goldman | Upgrade | Buy | $18← $15 |
| August 23rd 2024 | Piper Sandler | Resumed | Overweight | $18 |
Earnings History & Surprises
WRBYBeat Rate
47%
Last 17 quarters
Avg Surprise
-67.7%
EPS vs Estimate
Beats / Misses
8/6
3 met exactly
Latest EPS
$0.11
Q4 2025
EPS Surprise History
Q1 24
-232.2%
$-0.01vs$-0.00
Q2 24
+14.3%
$0.08vs$0.07
Q3 24
+20.0%
$0.06vs$0.05
Q4 24
0.0%
$0.05vs$0.05
Q1 25
-66.7%
$0.01vs$0.03
Q2 25
0.0%
$0.12vs$0.12
Q3 25
0.0%
$0.08vs$0.08
Q4 25
+22.2%
$0.11vs$0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.05 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.09 | $0.11 | +22.2% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.08 | $0.08 | 0.0% | = MET |
Q2 2025 | May 8, 2025 | $0.12 | $0.12 | 0.0% | = MET |
Q1 2025 | Feb 27, 2025 | $0.03 | $0.01 | -66.7% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.05 | $0.05 | 0.0% | = MET |
Q3 2024 | Aug 8, 2024 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.07 | $0.08 | +14.3% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $-0.00 | $-0.01 | -232.2% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $0.01 | $0.01 | +4.6% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | $0.02 | $0.04 | +73.9% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $-0.02 | $-0.17 | -663.4% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $0.01 | $0.01 | -32.6% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.01 | $-0.01 | -52.7% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.06 | $-0.30 | -383.8% | ✗ MISS |
Q1 2022 | Mar 17, 2022 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q4 2021 | Nov 12, 2021 | $-0.63 | $0.03 | +104.8% | ✓ BEAT |
Q3 2021 | Sep 29, 2021 | — | $0.27 | — | — |
Latest News
Piper Sandler Maintains Overweight on Warby Parker, Raises Price Target to $32
📈 PositiveBenzinga•Dec 16, 2025, 01:56 PM
Stifel Maintains Hold on Warby Parker, Raises Price Target to $25
📈 PositiveBenzinga•Dec 12, 2025, 04:11 PM•Also:
BTIG Maintains Buy on Warby Parker, Raises Price Target to $32
📈 PositiveBenzinga•Dec 11, 2025, 06:40 PM
Warby Parker after Google confirms AI glasses are set to arrive in 2026
📉 NegativeSeeking Alpha•Dec 8, 2025, 06:38 PM•Also: ,
Warby Parker And Google To Launch First Lightweight AI Glasses In 2026
📈 PositiveBenzinga•Dec 8, 2025, 06:16 PM•Also: ,
Telsey Advisory Group Maintains Outperform on Warby Parker, Maintains $24 Price Target
📈 PositiveBenzinga•Nov 18, 2025, 01:17 PM
UBS Maintains Neutral on Warby Parker, Lowers Price Target to $20
➖ NeutralBenzinga•Nov 7, 2025, 06:25 PM•Also:
Telsey Advisory Group Maintains Outperform on Warby Parker, Lowers Price Target to $24
📈 PositiveBenzinga•Nov 7, 2025, 01:38 PM
Warby Parker shares are trading lower after the company reported worse-than-expected Q3 sales results and cut its FY25 sales guidance below estimates.
📉 NegativeBenzinga•Nov 6, 2025, 01:14 PM
Warby Parker Lowers FY2025 Sales Guidance from $880.000M-$888.000M to $871.000M-$874.000M vs $885.967M Est
📉 NegativeBenzinga•Nov 6, 2025, 11:48 AM
Warby Parker Q3 EPS $0.05, Inline, Sales $221.680M Miss $224.494M Estimate
➖ NeutralBenzinga•Nov 6, 2025, 11:47 AM
Telsey Advisory Group Maintains Outperform on Warby Parker, Maintains $28 Price Target
📈 PositiveBenzinga•Oct 31, 2025, 11:28 AM
BTIG Reiterates Buy on Warby Parker, Maintains $28 Price Target
📈 PositiveBenzinga•Oct 28, 2025, 11:16 AM
Goldman Sachs Maintains Buy on Warby Parker, Raises Price Target to $31
📈 PositiveBenzinga•Oct 6, 2025, 05:59 PM
Shares of retail, apparel and consumer discretionary stocks are trading lower in possible reaction to a drop in consumer confidence. Concerns over a government shutdown could also be weighing on economic sentiment.
📉 NegativeBenzinga•Sep 30, 2025, 05:10 PM•Also: , ,
Warby Parker shares surge after Google commits up to $150M to develop AI glasses
📈 PositiveSeeking Alpha•May 20, 2025, 07:45 PM•Also: ,
Frequently Asked Questions about WRBY
What is WRBY's current stock price?
Warby Parker Inc. (WRBY) is currently trading at $26.39 per share. The stock has moved -1.27% today.
What is the analyst price target for WRBY?
The average analyst price target for WRBY is $31.20, based on 1 analyst.
What sector is Warby Parker Inc. in?
Warby Parker Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NYSE exchange.
What is WRBY's market cap?
Warby Parker Inc. has a market capitalization of $3.22 billion, making it a mid-cap company.
Does WRBY pay dividends?
No, Warby Parker Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBEAM
Beam Therapeutics Inc.
$26.57
Mkt Cap: $2.7B
BHC
Bausch Health Companies Inc.
$6.88
Mkt Cap: $2.5B
CON
Concentra Group Holdings Parent, Inc.
$19.43
Mkt Cap: $2.5B
HAE
Haemonetics Corporation
$80.21
Mkt Cap: $3.9B
ICUI
ICU Medical, Inc.
$145.15
Mkt Cap: $3.6B
ITGR
Integer Holdings Corporation
$78.58
Mkt Cap: $2.8B
LMAT
LeMaitre Vascular, Inc.
$84.96
Mkt Cap: $1.9B
PINC
Premier, Inc.
$28.26
Mkt Cap: $2.3B
QDEL
QuidelOrtho Corporation
$28.95
Mkt Cap: $2.0B
XRAY
DENTSPLY SIRONA Inc.
$11.21
Mkt Cap: $2.2B
Explore stocks similar to WRBY for comparison